Ac immune and takeda sign exclusive option and license agreement for active immunotherapy targeting amyloid beta for alzheimer's disease

Ac immune and takeda sign exclusive option and license agreement for active immunotherapy targeting amyloid beta for alzheimer's disease
ACIU Ratings Summary
ACIU Quant Ranking